A Phase I and Expansion Cohort Study of Venetoclax in Combination With Chemotherapy in Pediatric Patients With Refractory or Relapsed Acute Myeloid Leukemia
Phase of Trial: Phase I
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Venetoclax (Primary) ; Cytarabine; Cytarabine; Hydrocortisone; Idarubicin; Methotrexate
- Indications Acute biphenotypic leukaemia; Acute myeloid leukaemia; Leukaemia
- Focus Adverse reactions
- 17 Jan 2018 Planned End Date changed from 31 Aug 2020 to 1 Aug 2020.
- 17 Jan 2018 Planned primary completion date changed from 31 Aug 2020 to 1 Aug 2020.
- 06 Jul 2017 Status changed from not yet recruiting to recruiting.